23 May 2013
Keywords: protein, design, labs, buys, zenapax, 80m, usa
Article | 06 October 2003
The USA's Protein Design Laboratories says that it has obtained exclusive worldwide rights to Roche's transplant drug Zenaplax
(daclizumab), in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 October 2003
22 May 2013
© 2013 thepharmaletter.com